Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours

British Journal of Cancer, Published online: 09 December 2019; doi:10.1038/s41416-019-0674-4Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours

Source: British Journal of Cancer - December 8, 2019 Category: Cancer & Oncology Authors: Corran Roberts Victoria Y. Strauss Sylwia Kopijasz Charlie Gourley Marcia Hall Ana Montes Jacinta Abraham Andrew Clamp Richard Kennedy Susana Banerjee Lisa K. Folkes Michael Stratford Shibani Nicum Source Type: research